ALPS Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-32,516
Closed -$190K 1160
2022
Q4
$190K Buy
32,516
+6,319
+24% +$36.9K ﹤0.01% 1004
2022
Q3
$176K Sell
26,197
-468
-2% -$3.14K ﹤0.01% 1011
2022
Q2
$112K Buy
+26,665
New +$112K ﹤0.01% 1025
2021
Q2
Sell
-55,449
Closed -$277K 925
2021
Q1
$277K Buy
55,449
+1,807
+3% +$9.03K ﹤0.01% 837
2020
Q4
$678K Buy
53,642
+15,801
+42% +$200K 0.01% 437
2020
Q3
$372K Sell
37,841
-2,614
-6% -$25.7K 0.01% 496
2020
Q2
$403K Sell
40,455
-11,535
-22% -$115K 0.01% 483
2020
Q1
$460K Buy
51,990
+3,591
+7% +$31.8K 0.01% 447
2019
Q4
$446K Buy
48,399
+980
+2% +$9.03K ﹤0.01% 522
2019
Q3
$279K Sell
47,419
-2,380
-5% -$14K ﹤0.01% 815
2019
Q2
$598K Sell
49,799
-6,791
-12% -$81.5K ﹤0.01% 498
2019
Q1
$683K Sell
56,590
-32,029
-36% -$387K ﹤0.01% 418
2018
Q4
$1.11M Buy
88,619
+11,322
+15% +$142K 0.01% 285
2018
Q3
$1.15M Buy
77,297
+23,761
+44% +$353K 0.01% 350
2018
Q2
$901K Buy
53,536
+2,607
+5% +$43.9K 0.01% 356
2018
Q1
$1.17M Buy
50,929
+25,790
+103% +$590K 0.01% 283
2017
Q4
$650K Buy
25,139
+2,796
+13% +$72.3K ﹤0.01% 353
2017
Q3
$330K Buy
22,343
+1,981
+10% +$29.3K ﹤0.01% 718
2017
Q2
$284K Buy
20,362
+1,200
+6% +$16.7K ﹤0.01% 726
2017
Q1
$327K Sell
19,162
-2,244
-10% -$38.3K ﹤0.01% 682
2016
Q4
$220K Sell
21,406
-6,930
-24% -$71.2K ﹤0.01% 691
2016
Q3
$286K Sell
28,336
-2,874
-9% -$29K ﹤0.01% 646
2016
Q2
$350K Buy
+31,210
New +$350K ﹤0.01% 544
2016
Q1
Sell
-25,871
Closed -$491K 780
2015
Q4
$491K Hold
25,871
﹤0.01% 470
2015
Q3
$4.86K Buy
+25,871
New +$4.86K 0.01% 450